TARDBP | TAR DNA binding protein | Disease related genes Plasma proteins
| | | | | Expressed in all |
MASP2 | Mannan-binding lectin serine peptidase 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
EXOSC10 | Exosome component 10 | | | | | | Expressed in all |
AGTRAP | Angiotensin II receptor-associated protein | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C1orf167 | Chromosome 1 open reading frame 167 | | | | | | Group enriched |
NPPA | Natriuretic peptide A | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PLOD1 | Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
TNFRSF8 | Tumor necrosis factor receptor superfamily, member 8 | Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
DHRS3 | Dehydrogenase/reductase (SDR family) member 3 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
PDPN | Podoplanin | Predicted membrane proteins
| | | | | Tissue enhanced |
PRDM2 | PR domain containing 2, with ZNF domain | Enzymes Transcription factors
| | | | | Expressed in all |
KAZN | Kazrin, periplakin interacting protein | | | | | | Tissue enhanced |
TMEM51 | Transmembrane protein 51 | Predicted membrane proteins
| | | | | Mixed |
FHAD1 | Forkhead-associated (FHA) phosphopeptide binding domain 1 | | | | | | Group enriched |
EFHD2 | EF-hand domain family, member D2 | | | | | | Expressed in all |
CTRC | Chymotrypsin C (caldecrin) | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
AGMAT | Agmatine ureohydrolase (agmatinase) | Enzymes Mitochondrial proteins
| | | | | Tissue enhanced |
DDI2 | DNA-damage inducible 1 homolog 2 (S. cerevisiae) | Plasma proteins
| | | | | Expressed in all |
RSC1A1 | Regulatory solute carrier protein, family 1, member 1 | | | | | | Mixed |
TMEM82 | Transmembrane protein 82 | Predicted membrane proteins
| | | | | Group enriched |
SPEN | Spen family transcriptional repressor | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
EPHA2 | EPH receptor A2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
RSG1 | REM2 and RAB-like small GTPase 1 | | | | | | Mixed |
FBXO42 | F-box protein 42 | | | | | | Expressed in all |
NECAP2 | NECAP endocytosis associated 2 | | | | | | Expressed in all |
CROCC | Ciliary rootlet coiled-coil, rootletin | | | | | | Expressed in all |
MFAP2 | Microfibrillar-associated protein 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
SDHB | Succinate dehydrogenase complex, subunit B, iron sulfur (Ip) | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
PADI2 | Peptidyl arginine deiminase, type II | Enzymes
| | | | | Tissue enhanced |
PADI1 | Peptidyl arginine deiminase, type I | Enzymes
| | | | | Tissue enriched |
PADI4 | Peptidyl arginine deiminase, type IV | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enriched |
ARHGEF10L | Rho guanine nucleotide exchange factor (GEF) 10-like | | | | | | Expressed in all |
IGSF21 | Immunoglobin superfamily, member 21 | Predicted secreted proteins
| | | | | Tissue enhanced |
ALDH4A1 | Aldehyde dehydrogenase 4 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
UBR4 | Ubiquitin protein ligase E3 component n-recognin 4 | Cytoskeleton related proteins Predicted membrane proteins
| | | | | Expressed in all |
MRTO4 | MRNA turnover 4 homolog (S. cerevisiae) | Ribosomal proteins
| | | | | Expressed in all |
AKR7A2 | Aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) | Enzymes Plasma proteins
| | | | | Expressed in all |
PQLC2 | PQ loop repeat containing 2 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
CAPZB | Capping protein (actin filament) muscle Z-line, beta | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
MINOS1-NBL1 | MINOS1-NBL1 readthrough | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MINOS1 | Mitochondrial inner membrane organizing system 1 | Predicted membrane proteins
| | | | | Expressed in all |
RNF186 | Ring finger protein 186 | Predicted membrane proteins
| | | | | Tissue enhanced |
UBXN10 | UBX domain protein 10 | | | | | | Group enriched |
VWA5B1 | Von Willebrand factor A domain containing 5B1 | | | | | | Tissue enhanced |
MUL1 | Mitochondrial E3 ubiquitin protein ligase 1 | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
FAM43B | Family with sequence similarity 43, member B | | | | | | Tissue enriched |
CDA | Cytidine deaminase | Enzymes Plasma proteins
| | | | | Tissue enhanced |
PINK1 | PTEN induced putative kinase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
DDOST | Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (non-catalytic) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
SH2D5 | SH2 domain containing 5 | | | | | | Group enriched |